#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA825103	F	Concentration required for 50% cytotoxicity against human rhabdomyosarcoma cell lines	Homo sapiens	16		cell-based format	Scientific Literature
2.	ALA837821	F	inhibition concentration required against echovirus 9 was determined by plaque reduction assay	Echovirus	2		organism-based format	Scientific Literature
3.	ALA837248	F	inhibition concentration required against echovirus 29 was determined by plaque reduction assay	Echovirus	2		organism-based format	Scientific Literature
4.	ALA838002	F	inhibition concentration required against coxsackievirus A9 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
5.	ALA838003	F	inhibition concentration required against coxsackievirus B1 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
6.	ALA876776	F	inhibition concentration required against coxsackievirus B2 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
7.	ALA838004	F	inhibition concentration required against coxsackievirus B3 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
8.	ALA825155	F	inhibition concentration required against coxsackievirus B4 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
9.	ALA825156	F	inhibition concentration required against coxsackievirus B5 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
10.	ALA825157	F	inhibition concentration required against coxsackievirus B6 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
11.	ALA837328	F	inhibition concentration required against coxsackievirus A10 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
12.	ALA837329	F	inhibition concentration required against coxsackievirus A16 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
13.	ALA837330	F	inhibition concentration required against coxsackievirus A24 was determined by plaque reduction assay	Coxsackievirus	2		organism-based format	Scientific Literature
14.	ALA833773	F	inhibition concentration required against human enterovirus 68 was determined by plaque reduction assay	Enterovirus	2		organism-based format	Scientific Literature
15.	ALA834810	F	inhibition concentration required against human enterovirus 71 strain 4643 was determined by plaque reduction assay	Enterovirus	16		organism-based format	Scientific Literature
16.	ALA834793	F	inhibition concentration required against human enterovirus 71 (1743) genotype B was determined by plaque reduction assay	Enterovirus	2		organism-based format	Scientific Literature
17.	ALA833169	F	inhibition concentration required against human enterovirus 71 (2086) genotype C was determined by plaque reduction assay	Enterovirus	2		organism-based format	Scientific Literature
18.	ALA833170	F	inhibition concentration required against human enterovirus 71 (2231) genotype C was determined by plaque reduction assay	Enterovirus	2		organism-based format	Scientific Literature
19.	ALA833171	F	inhibition concentration required against human enterovirus 71 (4643) genotype C was determined by plaque reduction assay	Enterovirus	1		organism-based format	Scientific Literature
20.	ALA833172	F	inhibition concentration required against human enterovirus 71 (BrCr) genotype A was determined by plaque reduction assay	Enterovirus	2		organism-based format	Scientific Literature